News
News
20/09/2024
CosmeticBusiness
Three for beauty
L'Oréal, Abolis Biotechnologies and Evonik join forces
Together with biotech innovator Abolis Biotechnologies and global specialty manufacturer Evonik, L'Oréal now aims to advance the discovery, development and manufacturing of innovative and sustainable ingredients for beauty products. The agreement is supported by the respective minority shareholdings of L'Oréal and Evonik in Abolis. Together, they want to produce good, sustainable ingredients on a scale that meets global demand and that prioritises the goals of the L'Oréal group. Further information...